Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions
© Jordans et al; licensee BioMed Central Ltd. 2009
Received: 20 July 2009
Accepted: 22 September 2009
Published: 22 September 2009
Cysteine cathepsins are known to primarily cleave their substrates at reducing and acidic conditions within endo-lysosomes. Nevertheless, they have also been linked to extracellular proteolysis, that is, in oxidizing and neutral environments. Although the impact of reducing or oxidizing conditions on proteolytic activity is a key to understand physiological protease functions, redox conditions have only rarely been considered in routine enzyme activity assays. Therefore we developed an assay to test for proteolytic processing of a natural substrate by cysteine cathepsins which accounts for redox potentials and pH values corresponding to the conditions in the extracellular space in comparison to those within endo-lysosomes of mammalian cells.
The proteolytic potencies of cysteine cathepsins B, K, L and S towards thyroglobulin were analyzed under conditions simulating oxidizing versus reducing environments with neutral to acidic pH values. Thyroglobulin, the precursor molecule of thyroid hormones, was chosen as substrate, because it represents a natural target of cysteine cathepsins. Thyroglobulin processing involves thyroid hormone liberation which, under physiological circumstances, starts in the extracellular follicle lumen before being continued within endo-lysosomes. Our study shows that all cathepsins tested were capable of processing thyroglobulin at neutral and oxidizing conditions, although these are reportedly non-favorable for cysteine proteases. All analyzed cathepsins generated distinct fragments of thyroglobulin at extracellular versus endo-lysosomal conditions as demonstrated by SDS-PAGE followed by immunoblotting or N-terminal sequencing. Moreover, the thyroid hormone thyroxine was liberated by the action of cathepsin S at extracellular conditions, while cathepsins B, K and L worked most efficiently in this respect at endo-lysosomal conditions.
The results revealed distinct cleavage patterns at all conditions analyzed, indicating compartment-specific processing of thyroglobulin by cysteine cathepsins. In particular, proteolytic activity of cathepsin S towards the substrate thyroglobulin can now be understood as instrumental for extracellular thyroid hormone liberation. Our study emphasizes that the proteolytic functions of cysteine cathepsins in the thyroid are not restricted to endo-lysosomes but include pivotal roles in extracellular substrate utilization. We conclude that understanding of the interplay and fine adjustment of protease networks in vivo is better approachable by simulating physiological conditions in protease activity assays.
Proteolytic processes are of vital importance due to the irreversibility of peptide bond cleavage. Spatio-temporal regulation of proteolysis is therefore of highest significance in determining the fate of cells. To date more than 66.500 gene sequences have been annotated as coding for proteolytic enzymes. The diversity of proteases is further reflected in broad tissue-, compartment- and substrate specificities. Most of all protease genes encode for serine peptidases (~25.000 sequences), followed by metallo (~23.000) and cysteine peptidases (~10.400) [1, 2]. Because of this variety, one key issue of degradomics is to investigate networks of proteases in order to explain distinct proteolytic functions in the spatio-temporal context of substrate cleavage . It is common practice to employ proteolytic activity assays to achieve this goal.
In this report we focused on cysteine cathepsins B, K, L and S, and analyzed their processing patterns using a natural substrate, thyroglobulin (Tg), while taking into account the suspected redox- and pH values of the physiological cleavage environments.
It has been shown before that the cysteine cathepsins B, K, L and S are localized to the endo-lysosomal system of thyroid epithelial cells. Moreover, they are present at extracellular locations such as the apical plasma membrane and within the follicular lumen of the thyroid gland [4–9]. Generally, cysteine cathepsins of the papain superfamily are well known to engage in bulk protein turnover at the increasingly acidic pH values of endocytic compartments . Nevertheless, the proteolytic potency of cysteine cathepsins towards peptidic or natural substrates has been demonstrated to expand over a wide range including neutral pH values [4, 11, 12]. In fact, cysteine cathepsins were often accredited as extracellularly acting enzymes in vivo (for reviews, see [10, 13]). Diverse protocols are available that describe methods to perform activity assays of cysteine cathepsins at neutral conditions, usually after activation of the proteases by incubation with reducing agents [14–19]. In reality, however, the extracellular space is not only a neutral but also an oxidizing environment, as much as endosomes and lysosomes exhibit not only acidic but also reducing conditions.
In this study, we have chosen redox-values of -220 mV to mimic the reducing environment of the cysteine-rich endosomes and lysosomes [20–22]. Moreover, endo-lysosomes are characterized by increasingly acidic conditions [23–25], and we considered pH 6.0 and pH 5.0 as closely reflecting the endosomal and lysosomal milieu, respectively. On the other hand, the thyroid follicle lumen represents a secluded compartment in which the tight junctions between thyroid epithelial cells tie up the extracellular storage space for Tg from the intercellular spaces between thyrocytes [26, 27]. The follicle lumen is assumed to be neutral in pH thereby rendering Tg proteolysis by extracellular hydrolases unlikely (for reviews, see [26–28]). However, more recently we provided evidence for Tg proteolysis mediated by cysteine cathepsins within the extracellular thyroid follicle lumen before its endocytosis [6, 7]. Extracellularly stored Tg of the human thyroid follicle lumen is covalently cross-linked by disulfide bonds  which can be formed in a self-assisted fashion via the CXXC-boxes within Tg , thereby attesting an oxidizing milieu within the thyroid follicle lumen. Furthermore, the direct pericellular environment adjacent to the apical plasma membrane of thyroid epithelial cells is oxidizing due to the presence of an H2O2 generating system which enables thyroid peroxidase to iodinate Tg at neutral pH [31, 32]. We have chosen a value of -150 mV to mimic the extracellular space which is slightly more oxidizing than the range of -160 mV to -170 mV that was reported for the lumen of the endoplasmic reticulum .
This study aims at elucidating crucial roles of selected cysteine cathepsins in this sequence of prohormone processing. The development of an in vitro assay system mimicking the in situ pH and redox conditions enabled analysis of the potency of cathepsins B, K, L and S to cleave their natural substrate Tg and to liberate thyroid hormones under conditions simulating favorable (endo-lysosomal) versus non-favorable (extracellular) compartments.
Localization of cysteine cathepsins in the human thyroid gland
Establishment of buffers with stable redox potentials at distinct pH values
Determination of cleavage sites within Tg
Under neutral and oxidizing conditions mimicking the extracellular thyroid follicle lumen full-length Tg of approximately 330 kDa was cleaved by each of the cysteine cathepsins tested, even though these buffer conditions are considered as 'non-favorable' for proteolytic action of cysteine cathepsins (Figure 4A). The effectiveness of substrate-cleavage was obvious from the appearance of two fragments of approximately 250 and 200 kDa (Figure 4A, arrowheads), which were also detected when the assay buffers reflected more favorable endosomal cleavage conditions, i.e. a reducing and slightly acidic environment (Figure 4B, arrowheads). In addition to the high molecular mass fragments, all samples containing cathepsin S displayed a specific 70 kDa fragment under extracellular conditions (Figure 4A, arrow). The same-sized fragment was generated at conditions characteristic for endosomes and lysosomes by several combinations of cysteine cathepsins but notably not by cathepsin K alone or in combination with cathepsins L and S. The analysis of degradation patterns using assay conditions mimicking lysosomal cleavage revealed a number of low molecular mass fragments of Tg as generated by all cathepsin combinations (Figure 4C, arrows). Samples containing cathepsin L lacked the intact, full-length Tg (Figure 4C, dashed arrow), but contained numerous smaller fragments of 40-70 kDa (Figure 4C, asterisks). Note that all preparations contained equal amounts of Tg at the start of incubation with cysteine cathepsins under different conditions. The lanes were loaded after the incubation period with identically sized aliquots from each preparation. Hence, the absence of signal in certain lanes of the immunoblots is representative of extensive Tg degradation rather than being the result of unequal loading of the gels. Accordingly, blank or weakly labeled lanes indicate complete degradation of Tg by the respective cysteine cathepsin/s at these conditions. As a control of its stability, Tg was incubated in the respective buffers, but without any protease added (Figure 4A-C, last lanes).
In order to determine the cleavage sites that were used by cysteine cathepsins, characteristic Tg fragments were N-terminally sequenced (Figure 5). A band with a molecular mass of approximately 330 kDa exhibited the same N-terminus as unprocessed Tg in all instances, thus representing intact, full-length protein. Tg-fragments originating from proteolytic processing by cathepsin S under extracellular conditions had molecular masses of approximately 200 kDa, 170 kDa and 70 kDa. Two of these fragments exhibited newly generated N-termini, while the 70 kDa fragment showed the same N-terminus as unprocessed Tg. Arrowheads indicate relative positions of identified cleavage sites as deduced from N-terminal sequencing of extracellular- (Figure 5B) or endosomal-like Tg degradation (Figure 5C). In Figure 5D a scheme of lysosomal cleavage sites is depicted, which was determined by Dunn and colleagues [36, 37] under near-physiological conditions since lysosomal extracts were used to degrade Tg. The schematic drawings in Figure 5 illustrate that the cleavage sites varied within Tg depending on the conditions under which cleavage took place.
Analysis of physiological significance of Tg cleavage
One important mechanism to control protease activity is given by endogenous inhibitors, another is represented by the dependency of proteolytic enzymes on the pH and redox potential of the cleavage environment. Whereas pH sensitivity has been studied quite extensively (for review, see ), much less is known about their sensitivity to the redox potential of the environment. Endo-lysosomal cysteine proteases like cathepsins L and B are considered highly instable at neutral pH values with half lives of 1.3 and 15 minutes, respectively [40, 41]. The inactivation appears to be irreversible and is associated with a loss of native 3D structure. However, a few other cysteine cathepsins of the papain superfamily clan C1A display prolonged stability and activity at neutral pH values, cathepsins K and S are the most prominent examples [4, 11, 18]. In contrast, papain as well as cruzain exhibit stability at broad ranges of pH values and withstand neutral to even basic pH-conditions [42, 43]. On the other hand, other plant proteases are particularly prone to turn instable at pH values differing from their acidic optimum . These pronounced differences in the pH-dependent stability indicate that papain-like enzymes have evolved [44, 45] to play roles in a variety of biological processes, bringing proteolysis into milieus outside acidic endo-lysosomal compartments. Therefore, mammalian cysteine cathepsins might be the "specialists" in acidic environments, although they are still suited to perform their actions, at least temporarily, under the neutral pH-conditions of the extracellular space that are nowadays considered non-favorable or even "extreme" [5, 10, 46].
In fact, proteolytic activity of lysosomal cysteine peptidases in an environment exhibiting conditions opposite to the reducing and acidic milieu of endo-lysosomal compartments was not long ago considered to be a mission impossible. Oxidizing conditions enforce the formation of disulfide bonds by reactive thiol groups which makes the active site cysteine of cathepsins highly sensitive to oxidation. Thus, under reducing conditions, like it is assumed for the endo-lysosomal compartment, the activity of cysteine cathepsins should be considerably higher than in other compartments exhibiting oxidizing conditions, like e.g. the extracellular space. In the thyroid, however, the extracellular follicle lumen is the scene of action for the initial steps of thyroid hormone utilization, i.e. the solubilization of covalently cross-linked Tg and thyroxine liberation by proteolytic processing mediated primarily through cysteine cathepsins B, K, L and S .
Up to now, the hypothesis that cysteine peptidases hold proteolytic activity in oxidizing environments was rarely challenged experimentally due to the lack of suitable activity assays with conditions mimicking the in vivo situation in the most life-like fashion, i.e. at realistic pH and redox conditions in physiological settings. In situ, redox conditions in cellular compartments or in the extracellular space are achieved and maintained by redox pairs of which cysteine(Cys)-cystine(CySS) constitutes the prominent and natural redox-pair of the extracellular space and endo-lysosomal compartments . In keeping with this notion, exact values describing redox potentials are astonishingly scarce and have been reported for the cytosol (-221 mV to -236 mV) and the ER lumen (-160 mV to -170 mV) [21, 22, 33]. The latter represents an oxidizing intracellular compartment of protein folding in which disulfide bridges are formed and maintained, whereas the cytosol is clearly reducing. For the choice of our buffer system we used the (Cys)-(CySS) redox-pair to adjust the redox potential and we considered a redox potential of -220 mV suitable to simulate reducing conditions of endosomes and lysosomes. A redox value of -150 mV was adjusted for mimicking the extracellular space, i.e. we assumed a slightly more oxidizing milieu for the extracellular space than that observed for the ER lumen. Through the use of a two-buffer system with citric acid and sodium phosphate and through the addition of L-cysteine, we have established buffers with stable redox potentials at distinct pH values for in vitro analyses of proteolytic substrate processing potency.
Another critical factor in proteolytic profiling is the choice of substrate. Commonly, small synthetic substrates are used for standard protease activity assays. More recently it became mandatory to use natural substrates in in vitro assays to collect more appropriate data; especially considering that protease-substrate interaction may also affect enzyme activity . The cleavage of Tg by cathepsins is a naturally occurring process of high physiological importance , which makes Tg an excellent substrate in our proteolytic assays. The partial degradation of extracellularly stored full-length Tg within the thyroid follicle lumen is of great importance in vivo. It represents the necessary first step to produce smaller fragments of the pro-hormone that can easily be endocytosed to ensure endo-lysosomal processing and efficient thyroid hormone liberation. In the in vitro assay presented herein, partial proteolytic processing of full length Tg was achieved by all cathepsins, resulting in the generation of three distinct fragments even at neutral and oxidizing conditions. The abundance of low molecular mass Tg-fragments in lysosomal-mimicking conditions of this assay must be considered representative of an extensive overall cleavage of the substrate. It can therefore be deduced that all cysteine cathepsins tested exhibited highest proteolytic activities, indeed, under acidic and reducing conditions. This notion is in line with the catabolic function of cysteine cathepsins in situ which is mainly conducted within the endo-lysosomal compartment. We consider cathepsin L as the most potent peptidase to catabolize Tg within the lysosomes, because the respective samples lacked full-length, intact Tg almost entirely, but contained numerous smaller fragments of 40-70 kDa.
The application of several cathepsins at once proved to be efficient in well-directed substrate cleavage further strengthening results from our previous in vivo studies in which it was shown that a concerted action of cathepsins K and L is needed for T4 liberation in vivo . The results presented herein further support the conclusion that Tg-processing and thyroid hormone liberation is achieved by proteases acting consecutively towards efficient pro-hormone utilization. Cathepsin S proved to be the best-suited cysteine cathepsin to extracellularly liberate T4 from Tg, i.e. to conduct hormone liberation before the pro-hormone eventually reached endosomes and lysosomes. Cathepsin S was also able to liberate T4 under endosomal and lysosomal conditions, but then, it was not any more efficient than the other cysteine cathepsins tested. In fact, it has been shown that cathepsin S is the only cysteine cathepsin which is truly stable at neutral pH when analyzed under reducing conditions, whereas cathepsins K and L are unstable and cathepsin B exhibits limited stability at reducing and neutral pH conditions [11, 17, 18, 40, 41, 48]. Interestingly, an additional cleavage site for the combination of cathepsins K and S was determined within the N-terminal half of Tg at extracellular conditions as compared to cleavage by cathepsin S alone (Figure 5B). This might explain why liberation of T4 under these conditions was less effective when both, cathepsins K and S were used in contrast to combinations of cathepsin S with cathepsins B or L, in which the cathepsin S ability to utilize T4 from Tg clearly dominated (Figure 6A). However, it should be kept in mind that the assay conditions as presented herein differ significantly from those of previous studies in that we mimicked physiological conditions by testing cysteine cathepsins under oxidizing and neutral pH conditions. Therefore, our results gained by studying cleavage of their natural substrate Tg under such comparatively "extreme" non-favorable conditions clearly differ from the standard assay conditions in which the read-out is not physiological, but instead cleavage of synthetic substrates is monitored. Hence, we believe that the data presented here has to be interpreted on the background of physiological protein processing with the biologically significant read-out, that is, utilization of T4 by processing of the precursor Tg.
None of the cleavage sites used by any of the cysteine cathepsins tested was identical in both, extracellular and endosomal conditions, i.e. in the compartments of well-directed substrate processing. Thus, we conclude that preferential cleavage is largely up to the compartment in which substrate processing takes place. The presence of different sets of proteolytic enzymes in such compartments may allow for a combinatorial and sequential substrate cleavage. This is to say that specific cleavage sites are used in distinct environments, which provide stable, biochemically defined conditions for specific sets of enzymes, but do not necessarily exhibit the most favorable conditions for bulk proteolytic processing. This notion is further supported by comparative analysis of endosomal-typical cleavage with respect of lysosomal-typical cleavage sites, which completely lack analogies as has been determined by us (this study) and by Dunn and co-workers using isolated cathepsins or extracts of thyroid lysosomes [36, 37]. Even though the cysteine cathepsins B and L were included in both studies, only one cleavage-site (Figure 5B and 5D, arrows) was found to be alike in extracellular conditions (this study) and in Tg fragments identified in lysosomal extracts (studies by Dunn and colleagues [36, 37]). Interestingly, this particular cleavage site was not reproduced by identical cathepsins in different environments, but the extracellular-representative cleavage of Tg by cathepsin S (this study) generated an almost identical neo-N-terminus as the cathepsin B-mediated cleavage determined by Dunn and co-workers [36, 37]. Thus, although the amino acid sequence of the substrate itself predominantly dictates its cleavage, the specificity of substrate cleavage is additionally directed by the biochemical environment of cleavage and by the set of actually cleaving enzymes.
It is important to keep in mind that the extracellularly acting cysteine cathepsins in the thyroid follicle are derived from their secretion into the follicle lumen after being recruited out of endo-lysosomal compartments . It is generally accepted that the proteolytic activity of such already activated cysteine peptidases can be maintained under oxidizing conditions in the extracellular space for longer time intervals [10, 34, 49]. Since the proteolytic enzymes cleaving Tg in the thyroid follicle lumen have experienced a reducing and acidic environment for proper processing and activation before being secreted, they may as well contribute significantly to physiological thyroid hormone liberation by extracellular proteolysis of Tg.
Our study shows that a specific subcellular location is the key figure in the nature of proteolytic processing, i.e. timing and location of peptidase activities determine whether bulk protein turnover or, instead, specific substrate processing takes place. Importantly enough, the onset of many pathological processes like tumor cell metastasis, rheumatoid arthritis, pancreatitis or multiple sclerosis goes along with alterations in the patterns of cysteine cathepsin localization and with pericellular acidification which may well be suited to prolong the extracellular actions of these proteases (for reviews see [10, 13, 50]).
The routine to analyze cysteine cathepsin-mediated processing of Tg presented herein will be easily adaptable to investigate any protease's proteolytic potential towards any natural or artificial substrate. Hence, our approach is applicable in order to study the degradome in a physiological context at simulated in vivo conditions. By adapting our assay system to other proteases, we anticipate a better understanding of the interplay and fine-adjustments of protease-networks that control substrate processing in the determination of 'vital' or 'fatal' changes in cellular destiny. Comprehensive knowledge of proteolysis in physiological or pathological conditions, in turn, is critical for the development of effective treatments and novel therapeutics.
Depletion of non-covalently associated T4 from isolated human Tg
Purified human Tg [29, 51] was mixed with 200 μg/mL 8-anillino-1-naphtalene-sulfonic acid ammonium salt (ANS, Calbiochem/Merck, Darmstadt, Germany) and incubated on an end-over-end-rotator (14 rpm) for 1 h in order to dissociate non-covalently bound T4 from its precursor that is known to eventually function as a T4-binding protein. The mixture was cleared of free T4 by two subsequent incubations with an anion exchange resin, DOWEX 1 (1 × 8 chloride form, 200-400 mesh; 50 mg/mL; Sigma, Munich, Germany). The crude and fine resin parts were removed by two centrifugation steps at 1,000 and 30,000 × g for 10 and 20 minutes, respectively. Supernatants were used for protein determination according to Neuhoff .
Preparation of assay buffers
A two-component buffer system of (A) 200 mM citric acid and (B) 200 mM dibasic sodium phosphate was used. Specific volumes of (A) and (B) were mixed as indicated below and buffers were pre-warmed to 40°C (according to ) while constantly stirring. Redox potentials were adjusted by the addition of L-cysteine (Roth, Karlsruhe, Germany) in the indicated amounts. Adequacy and stability of pH and redox values were constantly monitored using a pH electrode (SenTix 81) and an electrode for redox control (SenTix ORP), both connected to an InoLab pH Level 1 (all WTW, Weilheim, Germany). The pH of 7.2 in the buffer simulating the extracellular space was achieved by mixing 6.9 mL of buffer A and 87.1 mL of buffer B. Upon the addition of 9.58 mg L-cysteine the redox potential of the buffer shifted to -150 mV. The buffers mimicking slightly acidic endosomal compartments (pH 6.0, -220 mV) and acidic lysosomal compartments (pH 5.0, -220 mV) were prepared by mixing 19.7 mL of buffer A and 68.3 mL of buffer B with 190 mg L-cysteine, or 28 mL of buffer A with 65.5 mL of buffer B and 2.2 g L-cysteine, respectively. Buffers were equilibrated at assay temperature before use.
In vitro Tg degradation assay
Cathepsins B and L, purified from human liver, were purchased from Calbiochem (Darmstadt, Germany), whereas human cathepsins K and S were recombinant enzymes [11, 18]. Human Tg and single cathepsins or combinations thereof were mixed in 100 μL of buffers mimicking extracellular, endosomal or lysosomal conditions to a final concentration of 9.5 pM for Tg, and 4.75 pM of either of the cathepsins. Therefore, the substrate to peptidase ratios varied from 1:0.5 up to 1:2 in single, double, triple, and quadruple cathepsin combinations. Samples were prepared in LowBind protein tubes (Eppendorf, Hamburg, Germany), spun down and incubated on an end-over-end rotator (40 rpm) for 2 hours at 40°C in a heated incubator. Then, samples were briefly centrifuged and processing of Tg was stopped either by freezing 50 μL aliquots of the samples at -20°C or by direct preparation of the samples for subsequent SDS-PAGE analysis. Samples were mixed with lithium dodecyl sulfate (LDS) sample buffer, heated to 70°C for 10 minutes, and 50 μL of each individual sample was loaded per lane. Gel-electrophoresis was performed in an XCell SureLock Mini-Cell using pre-cast 3-8% NuPAGE Novex Tris-Acetate gels and NuPAGE Tris-Acetate SDS running buffer (all Invitrogen, Karlsruhe, Germany) at 150 V for 75 minutes at RT. To ensure consistent running behavior, gels were loaded with samples from either of the three conditions so that reducing and non-reducing samples would not affect each other during separation. Subsequently, Tg and fragments were blotted onto polyvinylidenfluoride (PVDF) membranes at 30 V for 60 minutes using the XCell II Blotting Module and NuPAGE transfer buffer (all Invitrogen) according to the manufacturer's instructions.
Immunodetection of Tg and its degradation fragments
Membranes were blocked using 5% non-fat milk powder in PBS-Tween (0.34 M NaCl, 0.316 M Na2HPO4, 58.49 NaH2PO4, pH 7.2, supplemented with 0.3% Tween-20). Primary antibodies directed against bovine Tg  were diluted 1:1,000 in 2.5% non-fat milk powder and membranes were incubated 90 minutes at RT. Secondary, horseradish peroxidase (HRP) -coupled antibodies were allowed to bind for 60 minutes at RT. Immunoreactions were visualized by enhanced chemiluminescence (ECL) and imaged on CL-XPosure Clear Blue X-ray films (both Pierce, PerbioScience, Bonn, Germany) which were scanned using a transmitted light scanner device (OpticPro ST48, Plustek, Norderstedt, Germany).
N-terminal sequencing of separated Tg fragments
For sequencing, the degradation assays, gel-electrophoresis, and blotting were performed as above. The absolute content of cathepsins and Tg, however, was increased four-fold. PVDF membranes were briefly washed in ddH2O and stained overnight with 0.1% Coomassie R250 in 1% acetic acid and 40% methanol. Background was removed by washing in 50% methanol until bands became clearly visible. Selected protein bands showing adequate staining were cut and stored at -20°C until further analyzed by automated sequence analyses on a Procise pulsed-liquid protein sequencer (Applied Biosystems, Foster City, CA, USA).
Determination of thyroid hormone liberation by fT4-ELISA
To assess the amount of liberated thyroxine, 50 μL of the in vitro degradation samples were analyzed using a commercially available solid phase-based competitive immunoassay (DRG Diagnostics, Marburg, Germany). Serum samples that were included in the ELISA kit and contained defined fT4-amounts were used as standards. Serum standards and in vitro degradation samples were assayed in duplicates and treated equally in all respects. The assay was conducted according to the manufacturer's recommendation with the performance of optional washes (10 × 5 minutes) with ddH2O. Immediately after addition of the color reactant the absorbance at 450 nm was read in a microplate reader (MRX Microplate Reader, Dynatech Laboratories Inc., Chantilly, VA, USA). The fT4 amount calculated for blank values was subtracted from individual samples to accomplish normalization. Data presented are representative for n = 4 (for endosomal conditions) or n = 3 (for extracellular and lysosomal conditions); errors are given as standard deviations. Calculations were performed using Origin 7.0 (OriginLab Corporation, Northampton, MA, USA).
Immunolocalization of cysteine cathepsins in thyroid tissue
Biopsies of human thyroid tissue were taken from the non-disease affected regions after thyroidectomy. The use of human tissue was in compliance with the Helsinki Declaration and was approved to be conducted by WS and KB by the Ethics Commission of the Ärztekammer Bremen (Study 120 as of April 18th, 2005) in Germany. Tissue was fixed in 8% paraformaldehyde in 200 mM Hepes buffer, pH 7.4, and mounted in tissue freezing medium after several buffer exchanges. Cryo-sections were taken with a CM 1900 cryostat (Leica, Bensheim, Germany), and immunolabeled following routine procedures [4, 7] with sheep anti-human cathepsin B (RD Laboratorien, Diessen, Germany), mouse anti-human cathepsin K (IM 55, Oncogene through Merck Biosciences, Bad Soden, Germany), sheep anti-human cathepsin L (RD Laboratorien), and rabbit anti-human cathepsin S (kindly provided by Dr. E. Weber, Halle, Germany) as primary antibodies, followed by incubation with Alexa 488- or Alexa 546-labeled secondary antibodies (Molecular Probes through Invitrogen, Karlsruhe, Germany). Analysis of mounted tissue was performed by means of confocal laser scanning microscopy (LSM 510 Meta, Zeiss, Oberkochen, Germany).
The authors are indebted to Dr. E. Weber (Halle, Germany) for the kind gift of rabbit anti-human cathepsin S antibodies. The authors would like to thank Adrijana Leonardi (Toxicology Group, Jožef Stefan Institute) for help in the determination of Tg cleavage sites and recognize her outstanding expertise in N-terminal sequencing. Meike Klepsch is acknowledged for excellent technical assistance, in particular cryo-sectioning and immunolabeling. This work was supported by Jacobs University Bremen, then International University Bremen (to KB) and a Ph.D. student fellowship of the same University (to SJ) [both grant number 2140-90033], by an EMBO short term fellowship (to SJK) [grant number ASTF 168.00-03], by The Foundation BLANCEFLOR (to ST), by Slovenian Research Agency (to DT) [grant number P1-0048], and by NIH (to DB) [grant number AR 46182].
- Puente XS, Sanchez LM, Overall CM, Lopez-Otin C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003, 4 (7): 544-558. 10.1038/nrg1111.View ArticleGoogle Scholar
- Rawlings ND, Morton FR, Barrett AJ: MEROPS: the peptidase database. Nucleic Acids Res. 2006, D270-D272. 10.1093/nar/gkj089. 34 DatabaseGoogle Scholar
- Overall CM, Blobel CP: In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol. 2007, 8 (3): 245-257. 10.1038/nrm2120.View ArticleGoogle Scholar
- Tepel C, Bromme D, Herzog V, Brix K: Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci. 2000, 113 (Pt 24): 4487-4498.Google Scholar
- Brix K, Jordans S: Watching proteases in action. Nat Chem Biol. 2005, 1 (4): 186-187. 10.1038/nchembio0905-186.View ArticleGoogle Scholar
- Brix K, Linke M, Tepel C, Herzog V: Cysteine proteinases mediate extracellular prohormone processing in the thyroid. Biol Chem. 2001, 382 (5): 717-725. 10.1515/BC.2001.087.Google Scholar
- Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, Brix K: Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest. 2003, 111 (11): 1733-1745. 10.1172/JCI15990.View ArticleGoogle Scholar
- Linke M, Jordans S, Mach L, Herzog V, Brix K: Thyroid stimulating hormone upregulates secretion of cathepsin B from thyroid epithelial cells. Biol Chem. 2002, 383 (5): 773-784. 10.1515/BC.2002.081.View ArticleGoogle Scholar
- Linke M, Herzog V, Brix K: Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment. J Cell Sci. 2002, 115 (Pt 24): 4877-4889. 10.1242/jcs.00184.View ArticleGoogle Scholar
- Brix K, Dunkhorst A, Mayer K, Jordans S: Cysteine cathepsins: cellular roadmap to different functions. Biochimie. 2008, 90 (2): 194-207. 10.1016/j.biochi.2007.07.024.View ArticleGoogle Scholar
- Bromme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, Peters C, Thomas DY, Storer AC, Vernet T: Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. J Biol Chem. 1993, 268 (7): 4832-4838.Google Scholar
- Kirschke H, Barrett AJ, Rawlings ND: Proteinases 1: lysosomal cysteine proteinases. Protein Profile. 1995, 2 (14): 1581-1643.Google Scholar
- Mohamed MM, Sloane BF: Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer. 2006, 6 (10): 764-775. 10.1038/nrc1949.View ArticleGoogle Scholar
- Barrett AJ: Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J. 1980, 187 (3): 909-912.View ArticleGoogle Scholar
- Kooistra T, Millard PC, Lloyd JB: Role of thiols in degradation of proteins by cathepsins. Biochem J. 1982, 204 (2): 471-477.View ArticleGoogle Scholar
- Mason RW, Green GD, Barrett AJ: Human liver cathepsin L. Biochem J. 1985, 226 (1): 233-241.View ArticleGoogle Scholar
- Bromme D, Steinert A, Friebe S, Fittkau S, Wiederanders B, Kirschke H: The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. Biochem J. 1989, 264 (2): 475-481.View ArticleGoogle Scholar
- Bromme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 1996, 271 (4): 2126-2132. 10.1074/jbc.271.4.2126.View ArticleGoogle Scholar
- Hou WS, Li Z, Buttner FH, Bartnik E, Bromme D: Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem. 2003, 384 (6): 891-897. 10.1515/BC.2003.100.View ArticleGoogle Scholar
- Pisoni RL, Acker TL, Lisowski KM, Lemons RM, Thoene JG: A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis. J Cell Biol. 1990, 110 (2): 327-335. 10.1083/jcb.110.2.327.View ArticleGoogle Scholar
- Pillay CS, Dennison C: Cathepsin B stability, but not activity, is affected in cysteine:cystine redox buffers. Biol Chem. 2002, 383 (7-8): 1199-1204. 10.1515/BC.2002.132.View ArticleGoogle Scholar
- Pillay CS, Elliott E, Dennison C: Endolysosomal proteolysis and its regulation. Biochem J. 2002, 363 (Pt 3): 417-429. 10.1042/0264-6021:3630417.View ArticleGoogle Scholar
- Kornfeld S, Mellman I: The biogenesis of lysosomes. Annu Rev Cell Biol. 1989, 5: 483-525. 10.1146/annurev.cb.05.110189.002411.View ArticleGoogle Scholar
- Peters C, von Figura K: Biogenesis of lysosomal membranes. FEBS Lett. 1994, 346 (1): 108-114. 10.1016/0014-5793(94)00499-4.View ArticleGoogle Scholar
- Butor C, Griffiths G, Aronson NN, Varki A: Co-localization of hydrolytic enzymes with widely disparate pH optima: implications for the regulation of lysosomal pH. J Cell Sci. 1995, 108 (Pt 6): 2213-2219.Google Scholar
- Herzog V: Transcytosis in thyroid follicle cells. J Cell Biol. 1983, 97 (3): 607-617. 10.1083/jcb.97.3.607.View ArticleGoogle Scholar
- Herzog V: Pathways of endocytosis in thyroid follicle cells. Int Rev Cytol. 1984, 91: 107-139.View ArticleGoogle Scholar
- Wollman SH: Secretion of thyroid hormones. Lysosomes. 1969, 2: 483-512.Google Scholar
- Berndorfer U, Wilms H, Herzog V: Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked TG from human thyroids. J Clin Endocrinol Metab. 1996, 81 (5): 1918-1926. 10.1210/jc.81.5.1918.Google Scholar
- Klein M, Gestmann I, Berndorfer U, Schmitz A, Herzog V: The Thioredoxin Boxes of Thyroglobulin:Possible Implications for Intermolecular Disulfide Bond Formation in the Follicle Lumen. Biol Chem. 2000, 381 (7): 593-601. 10.1515/BC.2000.076.View ArticleGoogle Scholar
- Nunez J: Iodination and Thyroid Hormone Synthesis. The Thyroid Gland. Edited by: De Visscher M. 1980, New York: Raven Press, 39-59.Google Scholar
- Dupuy C, Kaniewski J, Dème D, Pommier J, Virion A: NADPH-dependent H2O2 generation catalyzed by thyroid plasma membranes. Studies with electron scavengers. Eur J Biochem. 1989, 185 (3): 597-603. 10.1111/j.1432-1033.1989.tb15155.x.View ArticleGoogle Scholar
- Hwang C, Sinskey AJ, Lodish HF: Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992, 257 (5076): 1496-1502. 10.1126/science.1523409.View ArticleGoogle Scholar
- Dehrmann FM, Coetzer TH, Pike RN, Dennison C: Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch Biochem Biophys. 1995, 324 (1): 93-98. 10.1006/abbi.1995.9924.View ArticleGoogle Scholar
- Dunn AD, Dunn JT: Thyroglobulin degradation by thyroidal proteases: action of thiol endopeptidases in vitro. Endocrinology. 1982, 111 (1): 290-298. 10.1210/endo-111-1-290.View ArticleGoogle Scholar
- Dunn AD, Crutchfield HE, Dunn JT: Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. J Biol Chem. 1991, 266 (30): 20198-20204.Google Scholar
- Dunn AD, Crutchfield HE, Dunn JT: Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology. 1991, 128 (6): 3073-3080. 10.1210/endo-128-6-3073.View ArticleGoogle Scholar
- Petanceska S, Devi L: Sequence analysis, tissue distribution, and expression of rat cathepsin S. J Biol Chem. 1992, 267 (36): 26038-26043.Google Scholar
- Turk B, Dolenc I, Turk V, Bieth JG: Kinetics of the pH-induced inactivation of human cathepsin L. Biochemistry. 1993, 32 (1): 375-380. 10.1021/bi00052a046.View ArticleGoogle Scholar
- Turk B, Dolenc I, Zerovnik E, Turk D, Gubensek F, Turk V: Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site. Biochemistry. 1994, 33 (49): 14800-14806. 10.1021/bi00253a019.View ArticleGoogle Scholar
- Turk B, Turk D, Turk V: Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta. 2000, 1477 (1-2): 98-111.View ArticleGoogle Scholar
- Zucker S, Buttle DJ, Nicklin MJH, Barrett AJ: The proteolytic activities of chymopapain, papain, and papaya proteinase III. Biochim Biophys Acta. 1985, 828 (2): 196-204.View ArticleGoogle Scholar
- Stepek G, Behnke JM, Buttle DJ, Duce IR: Natural plant cysteine proteinases as anthelmintics?. Trends Parasitol. 2004, 20 (7): 322-327. 10.1016/j.pt.2004.05.003.View ArticleGoogle Scholar
- Dickinson DP: Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med. 2002, 13 (3): 238-275. 10.1177/154411130201300304.View ArticleGoogle Scholar
- Barrett AJ, Rawlings ND: Evolutionary Lines of Cysteine Peptidases. Biol Chem. 2001, 382 (5): 727-733. 10.1515/BC.2001.088.View ArticleGoogle Scholar
- McKerrow JH, Engel JC, Caffrey CR: Cysteine Protease Inhibitors as Chemotherapy for Parasitic Infections. Bioorg Med Chem. 1999, 7 (4): 639-644. 10.1016/S0968-0896(99)00008-5.View ArticleGoogle Scholar
- Jonas CR, Gu LH, Nkabyo YS, Mannery YO, Avissar NE, Sax HC, Jones DP, Ziegler TR: Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am J Physiol Regul Integr Comp Physiol. 2003, 285 (6): R1421-1429.View ArticleGoogle Scholar
- Mort JS, Recklies AD, Poole AR: Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum. 1984, 27 (5): 509-515. 10.1002/art.1780270505.View ArticleGoogle Scholar
- Baici A: Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses. Biol Chem. 1998, 379 (8-9): 1007-1018.Google Scholar
- Turk B: Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 2006, 5 (9): 785-799. 10.1038/nrd2092.View ArticleGoogle Scholar
- Brix K, Summa W, Lottspeich F, Herzog V: Extracellularly occurring histone H1 mediates the binding of thyroglobulin to the cell surface of mouse macrophages. J Clin Invest. 1998, 102 (2): 283-293. 10.1172/JCI1614.View ArticleGoogle Scholar
- Neuhoff V, Philipp K, Zimmer HG, Mesecke S: A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe Seylers Z Physiol Chem. 1979, 360 (11): 1657-1670.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.